|
|
Volumn , Issue , 2005, Pages 183-187
|
|
Loss of response to imatinib: mechanisms and management.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 METHYL N (3 (4 METHYLIMIDAZOL 1 YL) 5 (TRIFLUOROMETHYL)PHENYL) 3 ((4 PYRIDIN 3 YLPYRIMIDIN 2 YL)AMINO)BENZAMIDE;
4-METHYL-N-(3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO)BENZAMIDE;
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
BCR ABL TYROSINE KINASE;
BCR-ABL TYROSINE KINASE;
DASATINIB;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
ALLOTRANSPLANTATION;
ARTICLE;
CHRONIC MYELOID LEUKEMIA;
DRUG ANTAGONISM;
DRUG RESISTANCE;
ENZYME ACTIVATION;
GENETICS;
GENOTYPE;
HUMAN;
METABOLISM;
METHODOLOGY;
MUTATION;
STEM CELL TRANSPLANTATION;
TREATMENT FAILURE;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
ENZYME ACTIVATION;
FUSION PROTEINS, BCR-ABL;
GENOTYPE;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MUTATION;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
STEM CELL TRANSPLANTATION;
THIAZOLES;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT FAILURE;
|
|
EID: 79959308232
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2005.1.183 Document Type: Article |
|
Times cited : (114)
|
|
References (0)
|
